News

08/03/2019

Sant Pau studies on the response to innate immunity against cancer

A study of Servei d'Hematologia de Sant Pau and the Complutense University of Madrid (UNC) reveals that the rhG-CSF factor has one innate immunological effect for a cancer-fighting disease. L'estudi "...

05/03/2019

Sant Pau obtiene una beca FEHH-Fundación CRIS 2018-2019

Dr. Silvana Novelli Canales, assistant to the Hematology Service of the Hospital and researcher of the Hematology and Transplant Group of the Research Institute, has obtained one of the two FEHH-Funda...

04/03/2019

Sant Pau participates in the genetic study on Alzheimer published in Nature Genetics

The IIB Sant Pau has participated in an article published in the journal <em>Nature Genetics</em> to which 20 countries have contributed. This unprecedented project has analysed more genet...

28/02/2019

The IIB Sant Pau, one of the four centres in the world that study the Syngap1 gene, the origin of a minority disease.

Minority diseases are those that affect less than 5 people per 10,000 inhabitants and the latest today, 28 February, marks its international day promoted by the European Organisation for Rare Diseases...

28/02/2019

The IIB Sant Pau leads the only European clinical study on Parkinson’s with dementia

Dr. Jaume Kulisevsky, director of the Sant Pau Biomedical Research Institute (IIB Sant Pau) and director of the Movement Disorders Unit of the Neurology Service of the Sant Pau Hospital, coordinates t...